Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-05T13:02:08.039Z Has data issue: false hasContentIssue false

Schizophrenia and hetero-aggressiveness: management and aggravating factors

Published online by Cambridge University Press:  19 July 2023

M. Chtibi*
Affiliation:
Arrazi University Psychiatric Hospital of Salé, Faculty of Medicine and Pharmacy of Rabat, Rabat, Morocco
H. Berrada
Affiliation:
Arrazi University Psychiatric Hospital of Salé, Faculty of Medicine and Pharmacy of Rabat, Rabat, Morocco
I. Hanine
Affiliation:
Arrazi University Psychiatric Hospital of Salé, Faculty of Medicine and Pharmacy of Rabat, Rabat, Morocco
S. Belbachir
Affiliation:
Arrazi University Psychiatric Hospital of Salé, Faculty of Medicine and Pharmacy of Rabat, Rabat, Morocco
A. Ouanass
Affiliation:
Arrazi University Psychiatric Hospital of Salé, Faculty of Medicine and Pharmacy of Rabat, Rabat, Morocco
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Schizophrenia is a severe mental illness but especially important in terms of its impact on the subject. The stigmatization of these patients is major, leading to a significant decrease in their quality of life. This is partly due to the media coverage of the rare cases of hetero-aggression.

The aggressiveness of schizophrenic subjects remains poorly known and little studied.

Objectives

The objectives of our study are to determine whether the prescription of second-generation antipsychotics is associated with lower levels of aggression than the prescription of first-generation antipsychotics and to identify aggravating factors.

Methods

Materials and methods: We used an anonymous questionnaire based on, in addition to individual status and conditions, a self-administered questionnaire to assess the degree of aggression (the Buss and Perry Aggression Questionnaire (BPAQ)).

Results

Our study demonstrated superiority of second-generation antipsychotics in preventing aggression in subjects with schizophrenia, as well as an association between increased aggression and low insight, low compliance and low social support. In addition, younger age, male gender, and lower education were associated with increased aggression.

Conclusions

The prevention of aggression would then begin with the management of psychotic symptoms and comorbid disorders, as well as work on the compliance and insight of these patients. However, the aggressive dimension persists in some of them.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.